We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$86.3B
AUM Growth
-$7.68B
(-8.2%)
Cap. Flow
-$13B
Cap. Flow
% of AUM
-15.06%
Top 10 Holdings %
Top 10 Hldgs %
22.87%
Holding
2,645
New
347
Increased
664
Reduced
827
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$198M |
| 2 |
PayPal
PYPL
|
+$179M |
| 3 |
Vail Resorts
MTN
|
+$177M |
| 4 |
HEICO Corp
HEI
|
+$160M |
| 5 |
S&P Global
SPGI
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$350M |
| 2 |
CDW
CDW
|
+$280M |
| 3 |
Alibaba
BABA
|
+$258M |
| 4 |
Public Storage
PSA
|
+$247M |
| 5 |
Labcorp
LH
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.92% |
| 4 | Industrials | 9.55% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
1401
DELISTED
Sleep Number
SNBR
| $65K | ﹤0.01% |
1,301
-1
| -0.1% | -$68 |
|
1402
Supernus Pharmaceuticals
SUPN
$2.77B
| $65K | ﹤0.01% |
2,038
+14
| +0.7% | +$429 |
|
1403
Tilray
TLRY
$622M
| $65K | ﹤0.01% |
838
| – | – |
|
|
HBP
1404
DELISTED
Huttig Building Products, Inc.
HBP
| $65K | ﹤0.01% |
6,120
+1,238
| +25% | +$11.8K |
|
1405
Benchmark Electronics
BHE
$2.96B
| $64K | ﹤0.01% |
2,568
+526
| +26% | +$13.4K |
|
1406
Clean Harbors
CLH
$16.3B
| $64K | ﹤0.01% |
578
+300
| +108% | +$29.6K |
|
1407
Establishment Labs
ESTA
$2.28B
| $64K | ﹤0.01% |
963
+492
| +104% | +$28.8K |
|
1408
Jefferies Financial Group
JEF
$13.1B
| $64K | ﹤0.01% |
2,068
-603
| -23% | -$20.5K |
|
1409
Ultragenyx Pharmaceutical
RARE
$2.55B
| $64K | ﹤0.01% |
896
+240
| +37% | +$16.7K |
|
1410
Senseonics Holdings Inc
SENS
$366M
| $64K | ﹤0.01% |
+1,639
| New | +$75K |
|
1411
Vericel Corp
VCEL
$2.31B
| $64K | ﹤0.01% |
1,680
-189
| -10% | -$6.82K |
|
1412
Oppenheimer Holdings
OPY
$1.2B
| $63K | ﹤0.01% |
1,448
| – | – |
|
1413
Prothena Corp
PRTA
$450M
| $63K | ﹤0.01% |
1,733
+657
| +61% | +$23.7K |
|
|
STR
1414
DELISTED
Sitio Royalties
STR
| $63K | ﹤0.01% |
2,364
| – | – |
|
1415
Vishay Intertechnology
VSH
$5.43B
| $63K | ﹤0.01% |
3,250
-4,892
| -60% | -$98.6K |
|
1416
World Kinect Corp
WKC
$1.86B
| $63K | ﹤0.01% |
2,358
+2,212
| +1,515% | +$61.4K |
|
1417
Albemarle
ALB
$15.5B
| $62K | ﹤0.01% |
282
-5,958
| -95% | -$1.26M |
|
1418
Bridgewater Bancshares
BWB
$603M
| $62K | ﹤0.01% |
3,738
| – | – |
|
1419
Progyny
PGNY
$2.2B
| $62K | ﹤0.01% |
+1,214
| New | +$52K |
|
1420
Insulet
PODD
$9.79B
| $62K | ﹤0.01% |
235
-68
| -22% | -$16.7K |
|
|
VRN
1421
DELISTED
Veren
VRN
| $62K | ﹤0.01% |
+8,656
| New | +$58.4K |
|
|
ROVR
1422
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $62K | ﹤0.01% |
+10,873
| New | +$65.1K |
|
1423
argenx
ARGX
$54.1B
| $61K | ﹤0.01% |
194
| – | – |
|
1424
A10 Networks
ATEN
$1.95B
| $61K | ﹤0.01% |
4,411
-12,152
| -73% | -$171K |
|
1425
Chemours
CC
$2.37B
| $61K | ﹤0.01% |
1,961
-2,782
| -59% | -$87K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Lazard Asset Management held 2,645 positions worth $86.3B, down 8.2% from $94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $13B in Q1 2022, closing 297 positions and reducing 827 holdings. Its most notable exit was Stericycle Inc, an estimated $70.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vail Resorts worth $169M.
- Lazard Asset Management's largest Q1 2022 buy was Vail Resorts: 649,949 shares worth $169M.
- Lazard Asset Management added most to Nike in Q1 2022, an estimated $198M increase.
- Lazard Asset Management's biggest Q1 2022 reduction was Medtronic, cutting an estimated $350M.
- Lazard Asset Management fully exited Stericycle Inc in Q1 2022, selling an estimated $70.3M.
- Lazard Asset Management's ten largest holdings make up 23% of its $86.3B portfolio in Q1 2022.
- Lazard Asset Management opened 347 new positions and closed 297 in Q1 2022.
- Lazard Asset Management's portfolio value fell 8.2% quarter-over-quarter to $86.3B.
Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.